Northeast Financial Consultants’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.33M | Buy |
10,689
+132
| +1% | +$103K | 0.34% | 45 |
|
2025
Q1 | $8.72M | Buy |
10,557
+601
| +6% | +$496K | 0.39% | 40 |
|
2024
Q4 | $7.69M | Buy |
9,956
+24
| +0.2% | +$18.5K | 0.32% | 47 |
|
2024
Q3 | $8.8M | Buy |
9,932
+97
| +1% | +$85.9K | 0.38% | 41 |
|
2024
Q2 | $8.9M | Buy |
9,835
+56
| +0.6% | +$50.7K | 0.41% | 38 |
|
2024
Q1 | $7.61M | Buy |
9,779
+3,662
| +60% | +$2.85M | 0.37% | 45 |
|
2023
Q4 | $3.57M | Buy |
6,117
+1,241
| +25% | +$723K | 0.2% | 72 |
|
2023
Q3 | $2.62M | Buy |
4,876
+365
| +8% | +$196K | 0.16% | 86 |
|
2023
Q2 | $2.12M | Sell |
4,511
-31,343
| -87% | -$14.7M | 0.13% | 97 |
|
2023
Q1 | $12.3M | Buy |
35,854
+13
| +0% | +$4.46K | 0.79% | 25 |
|
2022
Q4 | $13.1M | Buy |
35,841
+523
| +1% | +$191K | 0.89% | 25 |
|
2022
Q3 | $11.4M | Sell |
35,318
-683
| -2% | -$221K | 0.84% | 25 |
|
2022
Q2 | $11.7M | Buy |
36,001
+1,310
| +4% | +$425K | 0.81% | 24 |
|
2022
Q1 | $9.93M | Buy |
34,691
+57
| +0.2% | +$16.3K | 0.58% | 34 |
|
2021
Q4 | $9.57M | Hold |
34,634
| – | – | 0.58% | 33 |
|
2021
Q3 | $8M | Buy |
34,634
+46
| +0.1% | +$10.6K | 0.53% | 35 |
|
2021
Q2 | $7.94M | Buy |
34,588
+200
| +0.6% | +$45.9K | 0.53% | 37 |
|
2021
Q1 | $6.42M | Hold |
34,388
| – | – | 0.49% | 41 |
|
2020
Q4 | $5.81M | Hold |
34,388
| – | – | 0.48% | 37 |
|
2020
Q3 | $5.09M | Hold |
34,388
| – | – | 0.46% | 37 |
|
2020
Q2 | $5.65M | Hold |
34,388
| – | – | 0.54% | 35 |
|
2020
Q1 | $4.77M | Hold |
34,388
| – | – | 0.54% | 36 |
|
2019
Q4 | $4.52M | Hold |
34,388
| – | – | 0.4% | 52 |
|
2019
Q3 | $3.85M | Hold |
34,388
| – | – | 0.39% | 56 |
|
2019
Q2 | $3.81M | Sell |
34,388
-100
| -0.3% | -$11.1K | 0.39% | 48 |
|
2019
Q1 | $4.48M | Sell |
34,488
-1,490
| -4% | -$193K | 0.5% | 39 |
|
2018
Q4 | $4.16M | Buy |
+35,978
| New | +$4.16M | 0.58% | 38 |
|